Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Mid-range Performer
915.2500 7.65 (0.84%)
NSE Jan 02, 2026 14:22 PM
Volume: 29,356
 

logo
Alivus Life Sciences Ltd.
24 Jul 2021
915.25
0.84%
buy
by Ventura
Ventura
IPO NOTE
 
Number of FII/FPI investors decreased from 101 to 92 in Sep 2025 qtr
More from Alivus Life Sciences Ltd.
Recommended
Market trades higher, ITC falls as government imposes new cigarette excise duty
Trendlyne Marketwatch | 02 Jan 2026, 02:07PM
Will the smallcap investor run out of patience in 2026?
The Baseline | 01 Jan 2026, 11:23AM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021